Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-14-009355)

Filing Details

Accession Number:: 0001140361-14-009355
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-02-24 18:21:27
Reporting Period:: 2014-02-18

Filing Date:: 2014-02-24
Accepted Time:: 2014-02-24 18:21:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1379006	Nanoviricides Inc.	NNVC	Services-Commercial Physical & Biological Research (8731)	760674577

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1513285	Anil Diwan	135 Wood Street West Haven CT 06516	President	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-02-18	10,000	$3.58	1,976,347	No	4	P	Direct
Common Stock	Acquisiton	2014-02-18	5,000	$3.30	1,981,347	No	4	P	Direct
Common Stock	Acquisiton	2014-02-18	5,000	$3.57	1,986,347	No	4	P	Direct
Common Stock	Acquisiton	2014-02-18	5,000	$3.55	1,991,347	No	4	P	Direct
Common Stock	Acquisiton	2014-02-18	5,000	$3.62	1,996,347	No	4	P	Direct
Common Stock	Acquisiton	2014-02-18	5,000	$3.52	2,001,347	No	4	P	Direct
Common Stock	Acquisiton	2014-02-20	15,000	$3.80	2,016,347	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Includes 285,714 shares issuable upon exercise of options. Does not include 285,714 shares of the Company's Series A Convertible Preferred Stock ("Series A") or 9,531,429 shares of common stock and 2,050,000 shares of Series A owned by TheraCour Pharma, Inc., over which Dr. Diwan holds voting and dispositive power.